Est. 2001·3,000+ placements · six offices · four regions
M&A Activitycurated sourcedetected 2026-11-05 · confidence 80%

Last updated

Mayne Pharma: M&A Activity

Mayne Pharma is selling its international operations for A$55.5m (per headline) to concentrate on its US business, a divestiture that reshapes the group's footprint.

Source: GN — ASX:MYX Mayne Pharma

Who
Mayne Pharma · Australia & New Zealand
What happened
Mayne Pharma is selling its international operations for A$55.5m (per headline) to concentrate on its US business, a divestiture that reshapes the group's footprint.
When
2026-11-05
So what
Consolidation shifts the leadership question from growth to integration.

The leadership read

Consolidation shifts the leadership question from growth to integration. For Mayne Pharma in the sector, the demand moves toward transformation and integration leaders who can merge teams, systems and cultures without losing momentum. Across Oceania, watch whether the integration is properly resourced; deals are won or lost the year after they close.

Market context: The wider read — a Talent Market Index of 104.6 (Hot), up 3.6 month-on-month — shows Oceania signal flow easing (-2.1pts).

Mayne Pharma: 2 signals in the last 90 days; 0.1% of MitchelLake's Oceania signal flow; 3 tracked across 112 days.

MitchelLake in this thematic

Also at Mayne Pharma →

More signals across Oceania

M&A Activity · Oceania

Steadfast Group (ASX:SDF) →

Steadfast, an ASX-listed insurance broker, has agreed to a takeover scheme. The headline gives no acquirer or deal terms.

M&A Activity · Oceania

Qube Holdings →

Qube Holdings has been delisted from the ASX following a takeover led by Macquarie, completing a change of ownership from public to private control.

M&A Activity · Oceania

Alfabs Australia Limited →

Alfabs agreed to acquire the pump business assets of J&J Vac Pty Ltd, including eight UVU pumps, OEM manufacturing rights and transferred orders for four more units. Upfront consideration is A$2.0M plus up to A$2.0M contingent, with settlement expected November 2026.

M&A Activity · Oceania

Challenger Limited →

Challenger (ASX:CGF) had a bid rejected, and its share price is being assessed relative to that rejected bid.

M&A Activity · Oceania

Aerometrex →

Aerometrex (ASX:AMX) has engaged advisers to review strategic options, including potential corporate transactions.

M&A Activity · Oceania

Seven Media Group →

Shareholders overwhelmingly approved renaming the merged Southern Cross Media television, radio and newspaper group to Seven Media Group Limited, following a merger that the board is defending with associated cost cuts.

Where this lands in our work

Weekly briefing

Track companies like Mayne Pharma — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗